Stephen Resch
- Pharmacy top 1%
- Infectious Diseases top 2%
- HIV/AIDS Research and Interventions 18
- Viral gastroenteritis research and epidemiology 7
- Health top 2%
- Vaccine Coverage and Hesitancy 26
-
- Obesity, Physical Activity, Diet 11
- Emergency Medical Services top 1%
-
- Global Maternal and Child Health 18
-
- Health Systems, Economic Evaluations, Quality of Life 10
-
- Hepatitis Viruses Studies and Epidemiology 8
-
- COVID-19 epidemiological studies 8
- Co-authors
- Zachary J. WardSteven L. GortmakerMichael W. LongAngie L. CradockCatherine M. GilesY. Claire WangThomas G. WeiserAngela Y. Chang
- Cited by
- PharmacyInfectious DiseasesHealth
- Partner nations
- United StatesUnited KingdomSwitzerland
In The Last Decade
Stephen Resch
92 papers receiving 3.5k citations
Hit Papers
Peers
Comparison fields: 5 of 153
- Pharmacy 243
- Infectious Diseases 837
- Health 371
- Public Health, Environmental and Occupational Health 1.2k
- Emergency Medical Services 254
Countries citing papers authored by Stephen Resch
This map shows the geographic impact of Stephen Resch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Resch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Resch more than expected).
Fields of papers citing papers by Stephen Resch
This network shows the impact of papers produced by Stephen Resch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Resch. The network helps show where Stephen Resch may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Stephen Resch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 4 | |
| 3 | 2024 | 7 | |
| 4 | 2023 | 0 | |
| 5 | 2022 | 14 | |
| 6 | 2022 | 3 | |
| 7 | 2021 | 16 | |
| 8 | 2020 | 17 | |
| 9 | 2020 | 5 | |
| 10 | 2019 | 48 | |
| 11 | 2019 | 5 | |
| 12 | 2018 | 28 | |
| 13 | Projected Savings Through Public Health Voluntary Licences of HIV Drugs Negotiated By The Medicines Patent Pool (MPP) | 2017 | 1 |
| 14 | 2017 | 56 | |
| 15 | 2016 | 35 | |
| 16 | 2016 | 9 | |
| 17 | 2016 | 13 | |
| 18 | 2015 | 10 | |
| 19 | 2014 | 51 | |
| 20 | 2012 | 26 |
About Stephen Resch
Stephen Resch is a scholar working on Health, Infectious Diseases, Modeling and Simulation, Applied Microbiology and Biotechnology and Pharmacy, having authored 97 papers that have together received 3.6k indexed citations. Recurring topics across this work include Vaccine Coverage and Hesitancy (26 papers), HIV/AIDS Research and Interventions (18 papers), Global Maternal and Child Health (18 papers), Obesity, Physical Activity, Diet (11 papers), Health Systems, Economic Evaluations, Quality of Life (10 papers), Hepatitis Viruses Studies and Epidemiology (8 papers), COVID-19 epidemiological studies (8 papers) and Viral gastroenteritis research and epidemiology (7 papers). The work is most often cited by research in Pharmacy (243 citations), Infectious Diseases (837 citations), Health (371 citations), Public Health, Environmental and Occupational Health (1.2k citations) and Emergency Medical Services (254 citations). Stephen Resch has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Zachary J. Ward, Steven L. Gortmaker, Michael W. Long, Angie L. Cradock, Catherine M. Giles, Y. Claire Wang, Thomas G. Weiser, Angela Y. Chang, Robert Hecht and Lisa A. Robinson. Their work appears in journals such as Health Policy and Planning, Vaccine, PLoS ONE, American Journal of Preventive Medicine and The Lancet Global Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.